Daily Health Headlines

Cancer Patients in Poorer Countries Often Go Without Radiation

👤by HealthDay 0 comments 🕔Friday, September 30th, 2016

THURSDAY, Sept. 29, 2016 (HealthDay News) -- Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds.

"In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria.

She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay.

Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 percent, the study authors said.

The study was presented Monday at the annual meeting of the American Society for Radiation Oncology in Boston. Data and conclusions presented at meetings should be considered preliminary until peer-reviewed for publication in a medical journal.

"To eradicate this disparity, efforts should be made to improve access to radiation therapy," Fidarova said in a society news release.

"National radiation therapy strategy with realistic short-, mid- and long-term goals should be developed and incorporated into comprehensive national cancer control plans," she said. And obstacles to radiation therapy access should be addressed in the planning phase, she added.

-- Robert Preidt

Article Credits / Source

HealthDay

HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: American Society for Radiation Oncology, news release, Sept. 26, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!